[1]
Sleire, L.; Førde, H.E.; Netland, I.A.; Leiss, L.; Skeie, B.S.; Enger, P.∅. Drug repurposing in cancer; Pharma. Res, 2017, pp. 74-91.
[http://dx.doi.org/10.1016/j.phrs.2017.07.013] [PMID: 28712971]
[http://dx.doi.org/10.1016/j.phrs.2017.07.013] [PMID: 28712971]
[2]
Khachigian, L.M. Repurposing drugs for skin cancer. Curr. Med. Chem., 2020, 27(42), 7214-7221.
[http://dx.doi.org/10.2174/0929867327666191220103901] [PMID: 31858902]
[http://dx.doi.org/10.2174/0929867327666191220103901] [PMID: 31858902]
[3]
Torralba, M.; Farra, R.; Maddaloni, M.; Grassi, M.; Dapas, B.; Grassi, G. Drugs repurposing in high-grade serous ovarian cancer. Curr. Med. Chem., 2020, 27(42), 7222-7233.
[http://dx.doi.org/10.2174/0929867327666200713190520] [PMID: 32660396]
[http://dx.doi.org/10.2174/0929867327666200713190520] [PMID: 32660396]
[4]
Fernandes, S.; Cassani, M.; Pagliari, S.; Filipensky, P.; Cavalieri, F.; Forte, G. Tumor in 3D: in vitro complex cellular models to improve nanodrugs cancer therapy. Curr. Med. Chem., 2020, 27(42), 7234-7255.
[http://dx.doi.org/10.2174/0929867327666200625151134] [PMID: 32586245]
[http://dx.doi.org/10.2174/0929867327666200625151134] [PMID: 32586245]
Current Medicinal Chemistry
Title:Drug Repurposing in Human Cancers
Volume: 27 Issue: 42
Author(s): Gabriele Grassi and Mario Grassi
Affiliation:
Export Options
About this article
Cite this article as:
Grassi Gabriele and Grassi Mario , Drug Repurposing in Human Cancers, Current Medicinal Chemistry 2020; 27 (42) . https://dx.doi.org/10.2174/092986732742201105104417
DOI https://dx.doi.org/10.2174/092986732742201105104417 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
12
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective
Current Pharmaceutical Design Nanostructured Therapeutic Systems of PUFAs for the Treatment of Glioblastoma Multiforme
Current Drug Metabolism Versatile Applications of microRNA in Anti-Cancer Drug Discovery: From Therapeutics to Biomarkers
Current Drug Discovery Technologies Natural Products, Synthetic and Non-Nucleoside Compounds as Inhibitors of Enzymes Related to DNA: Update 2013
Current Enzyme Inhibition Phycobilins and Phycobiliproteins Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry The Recent Progresses on The Improved Therapy of Melanoma by Novel Drug Delivery Systems
Current Drug Targets 19F: A Versatile Reporter for Non-Invasive Physiology and Pharmacology Using Magnetic Resonance
Current Medicinal Chemistry Somatic Mutation Analyses in Studies of the Clonal Evolution and Diagnostic Targets of Prostate Cancer
Current Genomics The Role of PET/CT and SPECT/CT in Oncology Drug Development
Current Molecular Imaging (Discontinued) Dual Topoisomerase I / II Inhibitors in Cancer Therapy
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Food, Nutrition & Agriculture Src Family Kinases: Potential Targets for the Treatment of Human Cancer and Leukemia
Current Pharmaceutical Design Pathophysiology and Biomarkers for Breast Cancer: Management Using Herbal Medicines
Current Nutrition & Food Science Computational and Statistical Methods to Explore the Various Dimensions of Protein Evolution
Current Bioinformatics Formulations, Pharmacodynamic and Clinical Studies of Nanoparticles for Lung Cancer Therapy - An Overview
Current Drug Metabolism Sex Hormones and their Analogues in Neuroimmune Biology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions
Current Medicinal Chemistry Gene Therapy for Gastric Diseases
Current Gene Therapy Dihidro-β-Agarofuran Sesquiterpenes: A New Class of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in the Protozoan Parasite Leishmania
Current Pharmaceutical Design Adrenoceptors: Non Conventional Target for Breast Cancer?
Current Medicinal Chemistry